CRNX
Crinetics Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.62B
P/E Ratio
—
EPS
$-5.14
Beta
0.24
52W High
$57.99
52W Low
$25.83
50-Day MA
$37.55
200-Day MA
$41.60
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapies for rare endocrine diseases and endocrine-related tumors. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $18.07M |
| Gross Profit (TTM) | $-339.11M |
| EBITDA | $-541.62M |
| Operating Margin | -1308.00% |
| Return on Equity | -39.20% |
| Return on Assets | -24.70% |
| Revenue/Share (TTM) | $0.19 |
| Book Value | $12.16 |
| Price-to-Book | 2.82 |
| Price-to-Sales (TTM) | 200.27 |
| EV/Revenue | 131.34 |
| EV/EBITDA | -13.40 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 2873.00% |
| Shares Outstanding | $105.44M |
| Float | $95.58M |
| % Insiders | 1.59% |
| % Institutions | 120.19% |
Historical Volatility
HV 10-Day
57.05%
HV 20-Day
50.99%
HV 30-Day
64.61%
HV 60-Day
55.77%
HV Rank
88.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($83.14 target)
3
Strong Buy12
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/11/2026